Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 125

    1.

    Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats.

    Dong H, Altomonte J, Morral N, Meseck M, Thung SN, Woo SL.

    Diabetes. 2002 Jan;51(1):130-8.PMID: 11756332 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Hepatic insulin expression improves glycemic control in type 1 diabetic rats.

    Dong H, Morral N, McEvoy R, Meseck M, Thung SN, Woo SL.

    Diabetes Res Clin Pract. 2001 Jun;52(3):153-63.PMID: 11323084 [PubMed - indexed for MEDLINE]Related articles

    3.

    Auto-regulated hepatic insulin gene expression in type 1 diabetic rats.

    Chen R, Meseck ML, Woo SL.

    Mol Ther. 2001 Apr;3(4):584-90.PMID: 11319921 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats.

    Muzzin P, Eisensmith RC, Copeland KC, Woo SL.

    Mol Endocrinol. 1997 Jun;11(6):833-7.PMID: 9171246 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.

    Park YM, Woo S, Lee GT, Ko JY, Lee Y, Zhao ZS, Kim HJ, Ahn CW, Cha BS, Kim KS, Park CW, Lee HC.

    J Gene Med. 2005 May;7(5):621-9.PMID: 15651056 [PubMed - indexed for MEDLINE]Related articles

    6.

    Regulated hepatic insulin gene therapy of STZ-diabetic rats.

    Thulé PM, Liu JM.

    Gene Ther. 2000 Oct;7(20):1744-52.PMID: 11083496 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.

    Riu E, Mas A, Ferre T, Pujol A, Gros L, Otaegui P, Montoliu L, Bosch F.

    Diabetes. 2002 Mar;51(3):704-11.PMID: 11872670 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.

    Fujimori Y, Katsuno K, Ojima K, Nakashima I, Nakano S, Ishikawa-Takemura Y, Kusama H, Isaji M.

    Eur J Pharmacol. 2009 May 1;609(1-3):148-54. Epub 2009 Mar 10.PMID: 19281809 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gene therapy for diabetes mellitus in rats by hepatic expression of insulin.

    Kolodka TM, Finegold M, Moss L, Woo SL.

    Proc Natl Acad Sci U S A. 1995 Apr 11;92(8):3293-7.PMID: 7724555 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Association of insulin resistance with hyperglycemia in streptozotocin-diabetic pigs: effects of metformin at isoenergetic feeding in a type 2-like diabetic pig model.

    Koopmans SJ, Mroz Z, Dekker R, Corbijn H, Ackermans M, Sauerwein H.

    Metabolism. 2006 Jul;55(7):960-71.PMID: 16784971 [PubMed - indexed for MEDLINE]Related articles

    11.

    Glucose-responsive hepatic insulin gene therapy of spontaneously diabetic BB/Wor rats.

    Olson DE, Paveglio SA, Huey PU, Porter MH, Thulé PM.

    Hum Gene Ther. 2003 Oct 10;14(15):1401-13.PMID: 14577921 [PubMed - indexed for MEDLINE]Related articles

    12.

    Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats.

    Thulé PM, Campbell AG, Kleinhenz DJ, Olson DE, Boutwell JJ, Sutliff RL, Hart CM.

    Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E114-E122. Epub 2005 Aug 23.PMID: 16118252 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.

    Croze F, Prud'homme GJ.

    J Gene Med. 2003 May;5(5):425-37.PMID: 12731091 [PubMed - indexed for MEDLINE]Related articles

    14.

    Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.

    He CX, Shi D, Wu WJ, Ding YF, Feng DM, Lu B, Chen HM, Yao JH, Shen Q, Lu DR, Xue JL.

    World J Gastroenterol. 2004 Feb 15;10(4):567-72.PMID: 14966918 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Cholecystokinin octapeptide: a potential growth factor for pancreatic beta cells in diabetic rats.

    Kuntz E, Pinget M, Damgé P.

    JOP. 2004 Nov 10;5(6):464-75.PMID: 15536283 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Action of pelargonidin on hyperglycemia and oxidative damage in diabetic rats: implication for glycation-induced hemoglobin modification.

    Roy M, Sen S, Chakraborti AS.

    Life Sci. 2008 May 23;82(21-22):1102-10. Epub 2008 Apr 1.PMID: 18440560 [PubMed - indexed for MEDLINE]Related articles

    18.

    Glucose-regulated insulin production in hepatocytes.

    Alam T, Sollinger HW.

    Transplantation. 2002 Dec 27;74(12):1781-7.PMID: 12499898 [PubMed - indexed for MEDLINE]Related articles

    19.

    Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.

    Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P.

    Pharmacol Res. 2005 Oct;52(4):313-20.PMID: 15979893 [PubMed - indexed for MEDLINE]Related articles

    20.

    Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.

    Ren B, O'Brien BA, Swan MA, Koina ME, Nassif N, Wei MQ, Simpson AM.

    Diabetologia. 2007 Sep;50(9):1910-20. Epub 2007 Jun 28.PMID: 17598085 [PubMed - indexed for MEDLINE]Related articlesFree article